Case report: First report of haploidentical allogeneic hematopoietic stem cell transplantation from donors with mild alpha-thalassemia for acute leukemia

For acute leukemia (AL) with adverse prognostic factors, allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the standard care option after the first complete remission. Meanwhile, as the success of haploidentical HSCT (haplo-HSCT), haploidentical donors (HIDs) become a reliable choice...

全面介紹

書目詳細資料

Principais autores:	Wenshuai Zheng, Yamei Wu, Lixun Guan, Longcan Cheng, Yalei Hu, Min Tan, Yuhui Yang, Hongmei Ning
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2022-12-01
叢編:	Frontiers in Oncology
主題:	haploidentical donors thalassemia acute leukemia successful haploidentical allogeneic hematopoietic stem cell transplantation
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fonc.2022.986144/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!